LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
3.942 |
Evidence |
|
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
3.942 |
Evidence |
|
CASR |
CASR, GPRC2A, PCAR1: Extracellular calcium-sensing receptor precursor |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
3.937 |
Evidence |
|
HMGCS2 |
HMGCS2: Hydroxymethylglutaryl-CoA synthase, mitochondrial precursor |
MAT1A |
MAT1A, AMS1, MATA1: S-adenosylmethionine synthetase isoform type-1 |
3.932 |
Evidence |
|
RPL27 |
RPL27: 60S ribosomal protein L27 |
RPL8 |
RPL8: 60S ribosomal protein L8 |
3.932 |
Evidence |
|
TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
MAPKAPK3 |
MAPKAPK3: MAP kinase-activated protein kinase 3 |
3.93 |
Evidence |
|
APS |
SH2B2, APS: SH2B adapter protein 2 |
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
3.93 |
Evidence |
|
RPS6KA5 |
RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 |
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
3.93 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
3.93 |
Evidence |
|
RRAS |
RRAS: Ras-related protein R-Ras precursor |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
3.93 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
PLD1 |
PLD1: Phospholipase D1 |
3.927 |
Evidence |
|
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.927 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
3.927 |
Evidence |
|
FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.927 |
Evidence |
|
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
3.927 |
Evidence |
|
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
EEA1 |
EEA1, ZFYVE2: Early endosome antigen 1 |
3.927 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
3.927 |
Evidence |
|
MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
3.927 |
Evidence |
|
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
3.927 |
Evidence |
|
ETS1 |
ETS1, EWSR2: Protein C-ets-1 |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
3.927 |
Evidence |
|
AHR |
AHR: Aryl hydrocarbon receptor precursor |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
3.927 |
Evidence |
|
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.927 |
Evidence |
|
BRAF |
BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase |
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
3.927 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
3.927 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.92 |
Evidence |
|